Alithea Genomics
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- $8.1M
Investors
- 3
About Alithea Genomics
Based in Epalinges, Switzerland, and founded in 2020 by Bart Deplancke, Daniel Alpern, and Riccardo Dainese, Alithea Genomics operates as a biopharma industry background in bioengineering, molecular biology, genomics, and lab operations and also provides transcriptomics solutions for research and biomarker discovery. As of September 2023, Riccardo Dainese is the Chief Executive Officer (CEO) of the company. Alithea Genomics SA is a business that has created a low-cost transcriptomics system to help in biomedical advances. The company provides a transcriptomics platform that uses mercurius technology to reduce the costs of RNA sequencing while significantly boosting sample analysis capacity. This gives pharmaceutical companies the ability to do substantial biological research.
Who invested in Alithea Genomics
3 investors across 3 rounds
See all investors in Alithea Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alithea Genomics
Who invested in Alithea Genomics?
Alithea Genomics has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alithea Genomics raised?
Alithea Genomics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Alithea Genomics last raise money?
Alithea Genomics's most recent round on record is a Seed, in Mar 2026.
What does Alithea Genomics do?
Based in Epalinges, Switzerland, and founded in 2020 by Bart Deplancke, Daniel Alpern, and Riccardo Dainese, Alithea Genomics operates as a biopharma industry background in bioengineering, molecular biology, genomics, and lab operations and also provides transcriptomics solutions for research and biomarker discovery.
Where is Alithea Genomics headquartered?
Alithea Genomics is headquartered in Epalinges, Switzerland.
Which VCs invest in companies like Alithea Genomics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Alithea Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Alithea Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.